Update on Treatments for Endotoxemia

Veterinary Clinics of North America - Equine Practice

Volumn 25, Issue 2, 2009, Pages 259-270

  Kelmer, Gal ^a,b  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b UNIVERSITY OF TENNESSEE   (United States)

Author keywords

Colic; Endotoxemia; Horses; Lipopolysaccharide; Polymyxin B

Indexed keywords

ANIMAL; ANIMAL DISEASE; COLIC; ENDOTOXEMIA; HORSE; HORSE DISEASE; PATHOLOGY; REVIEW;

ANIMALS; COLIC; ENDOTOXEMIA; HORSE DISEASES; HORSES;

EQUIDAE;

EID: 67649544340     PISSN: 07490739     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cveq.2009.04.012     Document Type: Review

References (77)

1. Sykes B.W., and Furr M.O. Equine endotoxaemia-a state-of-the-art review of therapy. Aust Vet J 83 (2005) 45-50
2. Werners A.H., Bull S., and Fink-Gremmels J. Endotoxaemia: a review with implications for the horse. Equine Vet J 37 (2005) 371-383
3. van Eps A.W., and Pollitt C.C. Equine laminitis: cryotherapy reduces the severity of the acute lesion. Equine Vet J 36 (2004) 255-260
4. Bertone J.J., Gossett K.A., Shoemaker K.E., et al. Effect of hypertonic vs. isotonic saline solution on responses to sublethal Escherichia coli endotoxemia in horses. Am J Vet Res 51 (1990) 999-1007
5. Kreimeier U., and Messmer K. [Use of hypertonic saline solutions in intensive care and emergency medicine-developments and perspectives]. Klin Wochenschr 69 Suppl 26 (1991) 134-142
6. Kupper S., Mees S.T., Gassmann P., et al. Hydroxyethyl starch normalizes platelet and leukocyte adhesion within pulmonary microcirculation during LPS-induced endotoxemia. Shock 28 (2007) 300-308
7. Lv R., Zhou W., Zhang L.D., et al. Effects of hydroxyethyl starch on hepatic production of cytokines and activation of transcription factors in lipopolysaccharide-administered rats. Acta Anaesthesiol Scand 49 (2005) 635-642
8. Schaper J., Ahmed R., Schafer T., et al. Volume therapy with colloid solutions preserves intestinal microvascular perfusion in endotoxaemia. Resuscitation 76 (2008) 120-128
9. Pantaleon L.G., Furr M.O., McKenzie II H.C., et al. Cardiovascular and pulmonary effects of hetastarch plus hypertonic saline solutions during experimental endotoxemia in anesthetized horses. J Vet Intern Med 20 (2006) 1422-1428
10. Shuster R., Traub-Dargatz J., and Baxter G. Survey of diplomates of the American College of Veterinary Internal Medicine and the American College of Veterinary Surgeons regarding clinical aspects and treatment of endotoxemia in horses. J Am Vet Med Assoc 210 (1997) 87-92
11. Moore J.N., Garner H.E., Shapland J.E., et al. Prevention of endotoxin-induced arterial hypoxaemia and lactic acidosis with flunixin meglumine in the conscious pony. Equine Vet J 13 (1981) 95-98
12. Moore J.N., Hardee M.M., and Hardee G.E. Modulation of arachidonic acid metabolism in endotoxic horses: comparison of flunixin meglumine, phenylbutazone, and a selective thromboxane synthetase inhibitor. Am J Vet Res 47 (1986) 110-113
13. Moore J.N., and Morris D.D. Endotoxemia and septicemia in horses: experimental and clinical correlates. J Am Vet Med Assoc 200 (1992) 1903-1914
14. Tomlinson J.E., and Blikslager A.T. Effects of cyclooxygenase inhibitors flunixin and deracoxib on permeability of ischaemic-injured equine jejunum. Equine Vet J 37 (2005) 75-80
15. Tomlinson J.E., Wilder B.O., Young K.M., et al. Effects of flunixin meglumine or etodolac treatment on mucosal recovery of equine jejunum after ischemia. Am J Vet Res 65 (2004) 761-769
16. Matyjaszek S., Morton A., Freeman D., et al. Effects of flunixin meglumine on recovery of colonic mucosa from ischemia in horses. Am J Vet Res 70 (2009) 236-246
17. Morton A, Grosche A, Polyak M, et al. Effects of flunixin meglumine on permeability of ischaemic-injured equine large colon. Presented at the: Ninth International Equine Colic Research Symposium. Liverpool, UK, June 15-18, 2008.
18. Semrad S.D., Hardee G.E., Hardee M.M., et al. Low dose flunixin meglumine: effects on eicosanoid production and clinical signs induced by experimental endotoxaemia in horses. Equine Vet J 19 (1987) 201-206
19. Cook V, Meyer C, Campbell N, et al. Effect of firocoxib or flunixin meglumine on recovery of ischaemic-injured equine jejunum. In: Ninth International Equine Colic Research Symposium, Liverpool UK, p. 68.
20. Lepper P.M., Held T.K., Schneider E.M., et al. Clinical implications of antibiotic-induced endotoxin release in septic shock. Intensive Care Med 28 (2002) 824-833
21. Bentley A.P., Barton M.H., Lee M.D., et al. Antimicrobial-induced endotoxin and cytokine activity in an in vitro model of septicemia in foals. Am J Vet Res 63 (2002) 660-668
22. Kusser W.C., and Ishiguro E.E. Effects of aminoglycosides and spectinomycin on the synthesis and release of lipopolysaccharide by Escherichia coli. Antimicrobial Agents Chemother 32 (1988) 1247-1250
23. Lamp K.C., Rybak M.J., McGrath B.J., et al. Influence of antibiotic and E5 monoclonal immunoglobulin M interactions on endotoxin release from Escherichia coli and Pseudomonas aeruginosa. Antimicrobial Agents Chemother 40 (1996) 247-252
24. Schleining J.A., and Reinertson E.L. Evidence for dimethyl sulphoxide (DMSO) use in horses. Part 2: DMSO as a parenteral anti-inflammatory agent and as a pharmacological carrier. Equine Vet Educ 19 (2007) 598-599
25. Hammond R.A., Hannon R., Frean S.P., et al. Endotoxin induction of nitric oxide synthase and cyclooxygenase-2 in equine alveolar macrophages. Am J Vet Res 60 (1999) 426-431
26. Brackett D.J., Lerner M.R., and Wilson M.F. Dimethyl sulfoxide antagonizes hypotensive, metabolic, and pathologic responses induced by endotoxin. Circ Shock 33 (1991) 156-163
27. DeForge L.E., Fantone J.C., Kenney J.S., et al. Oxygen radical scavengers selectively inhibit interleukin 8 production in human whole blood. J Clin Invest 90 (1992) 2123-2129
28. Sekizuka E., Benoit J.N., Grisham M.B., et al. Dimethylsulfoxide prevents chemoattractant-induced leukocyte adherence. Am J Physiol 256 (1989) H594-H597
29. Cetin M., Eser B., Er O., et al. Effects of DMSO on platelet functions and P-selectin expression during storage. Transfus Apheresis Sci 24 (2001) 261-267
30. Rosenblum W. Dimethyl sulfoxide effects on platelet aggregation and vascular reactivity in pial microcirculation. Ann N Y Acad Sci 411 (1983) 110-119
31. Essani N.A., Fisher M.A., and Jaeschke H. Inhibition of NF-kappa B activation by dimethyl sulfoxide correlates with suppression of TNF-alpha formation, reduced ICAM-1 gene transcription, and protection against endotoxin-induced liver injury. Shock 7 (1997) 90-96
32. Dabareiner R.M., White N.A., Snyder J.R., et al. Effects of Carolina rinse solution, dimethyl sulfoxide, and the 21-aminosteroid, U-74389G, on microvascular permeability and morphology of the equine jejunum after low-flow ischemia and reperfusion. Am J Vet Res 66 (2005) 525-536
33. Sullins K.E., White N.A., Lundin C.S., et al. Prevention of ischaemia-induced small intestinal adhesions in foals. Equine Vet J 36 (2004) 370-375
34. Kelmer G., Doherty T.J., Elliott S., et al. Evaluation of dimethyl sulphoxide effects on initial response to endotoxin in the horse. Equine Vet J 40 (2008) 358-363
35. Moore R.M., Muir W.W., Bertone A.L., et al. Effects of dimethyl sulfoxide, allopurinol, 21-aminosteroid U-74389G, and manganese chloride on low-flow ischemia and reperfusion of the large colon in horses. Am J Vet Res 56 (1995) 671-687
36. Reeves M.J., Vansteenhouse J., Stashak T.S., et al. Failure to demonstrate reperfusion injury following ischaemia of the equine large colon using dimethyl sulphoxide. Equine Vet J 22 (1990) 126-132
37. Van Hoogmoed L.M., Nieto J.E., Snyder J.R., et al. Survey of prokinetic use in horses with gastrointestinal injury. Vet Surg 33 (2004) 279-285
38. Traut U., Brugger L., Kunz R., et al. Systemic prokinetic pharmacologic treatment for postoperative adynamic ileus following abdominal surgery in adults. Cochrane Database Syst Rev (2008) CD004930
39. Brianceau P., Chevalier H., Karas A., et al. Intravenous lidocaine and small-intestinal size, abdominal fluid, and outcome after colic surgery in horses. J Vet Intern Med 16 1 (2002) 736-741
40. Malone E., Ensink J., Turner T., et al. Intravenous continuous infusion of lidocaine for treatment of equine ileus. Vet Surg 35 (2006) 60-66
41. Milligan M., Beard W., Kukanich B., et al. The effect of lidocaine on postoperative jejunal motility in normal horses. Vet Surg 36 (2007) 214-220
42. Nieto J.E., Rakestraw P.C., Snyder J.R., et al. In vitro effects of erythromycin, lidocaine, and metoclopramide on smooth muscle from the pyloric antrum, proximal portion of the duodenum, and middle portion of the jejunum of horses. Am J Vet Res 61 (2000) 413-419
43. Okamura K., Sasaki N., Yamada M., et al. Effects of mosapride citrate, metoclopramide hydrochloride, lidocaine hydrochloride, and cisapride citrate on equine gastric emptying, small intestinal and caecal motility. Res Vet Sci 86 (2009) 302-308
44. Rusiecki K., Nieto J., Puchalski S., et al. Evaluation of continuous infusion of lidocaine on gastrointestinal tract function in normal horses. Vet Surg 37 (2008) 564-570
45. Wiemer P, Laan T, Lashley M: Equine post operative ileus: comparison between continuous lidocaine infusion and other prokinetic medications. In: The International Equine Colic Research Symposium, Liverpool, p. 57.
46. Robertson S.A., Sanchez L.C., Merritt A.M., et al. Effect of systemic lidocaine on visceral and somatic nociception in conscious horses. Equine Vet J 37 (2005) 122-127
47. Cook V.L., and Blikslager A.T. Use of systemically administered lidocaine in horses with gastrointestinal tract disease. J Am Vet Med Assoc 232 (2008) 1144-1148
48. Taniguchi T., Shibata K., Yamamoto K., et al. Effects of lidocaine administration on hemodynamics and cytokine responses to endotoxemia in rabbits. Crit Care Med 28 (2000) 755-759
49. Morresey P.R., and Mackay R.J. Endotoxin-neutralizing activity of polymyxin B in blood after IV administration in horses. Am J Vet Res 67 (2006) 642-647
50. Falagas M.E., and Kasiakou S.K. Toxicity of polymyxins: a systematic review of the evidence from old and recent studies. Crit Care 10 (2006) R27
51. Coyne C.P., and Fenwick B.W. Inhibition of lipopolysaccharide-induced macrophage tumor necrosis factor-alpha synthesis by polymyxin B sulfate. Am J Vet Res 54 (1993) 305-314
52. Durando M.M., MacKay R.J., Linda S., et al. Effects of polymyxin B and Salmonella typhimurium antiserum on horses given endotoxin intravenously. Am J Vet Res 55 (1994) 921-927
53. Barton M.H., Parviainen A., and Norton N. Polymyxin B protects horses against induced endotoxaemia in vivo. Equine Vet J 36 (2004) 397-401
54. Parviainen A.K., Barton M.H., and Norton N.N. Evaluation of polymyxin B in an ex vivo model of endotoxemia in horses. Am J Vet Res 62 (2001) 72-76
55. Barton M. Use of polymyxin B for treatment of endotoxemia in horses. Comp Cont Edu Pract Vet 22 (2000) 1056-1059
56. Bell R.F., Dahl J.B., Moore R.A., et al. Peri-operative ketamine for acute post-operative pain: a quantitative and qualitative systematic review (Cochrane review). Acta Anaesthesiol Scand 49 (2005) 1405-1428
57. Gomez de Segura I.A., De Rossi R., Santos M., et al. Epidural injection of ketamine for perineal analgesia in the horse. Vet Surg 27 (1998) 384-391
58. Lopez-Sanroman F.J., Cruz J.M., Santos M., et al. Evaluation of the local analgesic effect of ketamine in the palmar digital nerve block at the base of the proximal sesamoid (abaxial sesamoid block) in horses. Am J Vet Res 64 (2003) 475-478
59. Peterbauer C., Larenza P.M., Knobloch M., et al. Effects of a low dose infusion of racemic and S-ketamine on the nociceptive withdrawal reflex in standing ponies. Vet Anaesth Analg 35 (2008) 414-423
60. Helmer K.S., Suliburk J.W., and Mercer D.W. Ketamine-induced gastroprotection during endotoxemia: role of heme-oxygenase-1. Dig Dis Sci 51 (2006) 1571-1581
61. Suliburk J.W., Helmer K.S., Gonzalez E.A., et al. Ketamine attenuates liver injury attributed to endotoxemia: role of cyclooxygenase-2. Surgery 138 (2005) 134-140
62. Yu M., Shao D., Feng X., et al. Effects of ketamine on pulmonary TLR4 expression and NF-kappa-B activation during endotoxemia in rats. Methods Find Exp Clin Pharmacol 29 (2007) 395-399
63. Taniguchi T., Shibata K., and Yamamoto K. Ketamine inhibits endotoxin-induced shock in rats. Anesthesiology 95 (2001) 928-932
64. Yu Y., Zhou Z., Xu J., et al. Ketamine reduces NFkappaB activation and TNFalpha production in rat mononuclear cells induced by lipopolysaccharide in vitro. Ann Clin Lab Sci 32 (2002) 292-298
65. Lankveld D.P., Bull S., Van Dijk P., et al. Ketamine inhibits LPS-induced tumour necrosis factor-alpha and interleukin-6 in an equine macrophage cell line. Vet Res 36 (2005) 257-262
66. Serikov V.B., Glazanova T.V., Jerome E.H., et al. Tyloxapol attenuates the pathologic effects of endotoxin in rabbits and mortality following cecal ligation and puncture in rats by blockade of endotoxin receptor-ligand interactions. Inflammation 27 (2003) 175-190
67. Staub Sr. N.C., Longworth K.E., Serikov V., et al. Detergent inhibits 70-90% of responses to intravenous endotoxin in awake sheep. J Appl Phys 90 (2001) 1788-1797
68. Longworth K.E., Smith B.L., Staub N.C., et al. Use of detergent to prevent initial responses to endotoxin in horses. Am J Vet Res 57 (1996) 1063-1066
69. Bertok L. Bile acids in physico-chemical host defence. Pathophysiology 11 (2004) 139-145
70. Winchell W.W., Hardy J., Levine D.M., et al. Effect of administration of a phospholipid emulsion on the initial response of horses administered endotoxin. Am J Vet Res 63 (2002) 1370-1378
71. Chien J.Y., Jerng J.S., Yu C.J., et al. Low serum level of high-density lipoprotein cholesterol is a poor prognostic factor for severe sepsis. Crit Care Med 33 (2005) 1688-1693
72. Goldfarb R.D., Parker T.S., Levine D.M., et al. Protein-free phospholipid emulsion treatment improved cardiopulmonary function and survival in porcine sepsis. Am J Physiol Regul Integr Comp Physiol 284 (2003) R550-R557
73. Gordon B.R., Parker T.S., Levine D.M., et al. Neutralization of endotoxin by a phospholipid emulsion in healthy volunteers. J Infect Dis 191 (2005) 1515-1522
74. Moore J.N., Norton N., Barton M.H., et al. Rapid infusion of a phospholipid emulsion attenuates the effects of endotoxaemia in horses. Equine Vet J 39 (2007) 243-248
75. Ronco C., Ricci Z., and Bellomo R. Importance of increased ultrafiltration volume and impact on mortality: sepsis and cytokine story and the role of continuous veno-venous haemofiltration. Curr Opin Nephrol Hypertens 10 (2001) 755-761
76. Veenman J.N., Dujardint C.L., Hoek A., et al. High volume continuous venovenous haemofiltration (HV-CVVH) in an equine endotoxaemic shock model. Equine Vet J 34 (2002) 516-522
77. Cruz D.N., Perazella M.A., Bellomo R., et al. Effectiveness of polymyxin B-immobilized fiber column in sepsis: a systematic review. Crit Care 11 (2007) R47